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EPIDEMIOLOGY NEWS 
Tuberculosis as an AIDS-defining disease in Europe 
In Europe, a centralized system for AIDS surveillance 
was set up in 1984 by the European Centre for the 
Epidemiological Monitoring of AIDS. Extrapul- 
monary tuberculosis (TB) was added to the list of 
AIDS-defining diseases in 1987, and pulmonary TB 
was included in the European AIDS surveillance case 
definition in 1993. The analysis of data from the 
European AIDS surveillance system provides a unique 
opportunity to assess the importance, the main 
characteristics and the trends of TB among European 
patients as an AIDS-defining disease. 
Data on AIDS cases diagnosed among adults and 
adolescents (2 15 years) reported by 31 March 1995 
(Denmark: cases reported by 30 June 1995) were used 
to evaluate risk factors associated with the occurrence 
of TB as an AIDS-defining condition. Because the 
AIDS case definition has changed twice, the analysis 
was performed for two separate time intervals: (1) 
between 1 January 1988 (date of implementation of 
the 1987 AIDS case definition in all European 
countries) and 31 December 1992, to characterize 
extra-pulmonary TB in 12 EU countries (Austria, 
Belgium, Denmark, France, Germany, Ireland, Italy, 
Norway, Portugal, Spain, Switzerland, UK); and (2) 
between 1 January 1994 (date by which the 1993 
European AIDS surveillance case definition had been 
implemented in all European countries) and 31 
December 1994 in 11 countries (Austria, Belgium, 
Denmark, France, Germany, Greece, Italy, Portugal, 
Spain, Switzerland, UK) for pulmonary and extra- 
pulmonary TB. 
Extrapulmonary tuberculosis - AIDS cases diagnosed 
between 1988 and 1992 
The study population (all adult and adolescent AIDS 
cases diagnosed between 1988 and 1992 in the 12 
selected countries) included 73,658 cases and accounted 
for 94.2% of all adult/adolescent AIDS cases reported 
in the WHO European Region in the same period. Of  
these 73,658 cases, 8002 (10.9%) were diagnosed with 
extrapulmonary TB. The proportion of cases with 
extrapulmonary TB remained stable over time (10.6% 
in 1988, 10.5%) in 1989, 11.0%) in 1990, 1991 and 
1992) and did not chffer significantly by gender (10.8% 
in males, 11.3% in females). O n  the other hand, it 
decreased significantly with age: 15.3% among patients 
aged < 30 years, 10.7% among those aged 30 to 39 
years, 5.6% among those aged 40 to 49 years, and 4.8% 
among those aged 2 50 years ( p  < 0.01). 
The proportion of AIDS cases diagnosed with 
extrapulmonary TB differed considerably according to 
the country of diagnosis: 2.1% in Norway, 2.2% in 
Denmark, 2.9% in the UK, 3.1% in Switzerland, 3.2% 
in Germany, 3.8% in Italy, 5.4% in Austria, 5.5% in 
Ireland, 5.7% in France, 8.4% in Belgium, 28.3% in 
Portugal and 30.0% in Spain. Differences by trans- 
mission group were also observed; the highest 
proportion was observed among intravenous drug 
users (IDUs, 17.3%) and the lowest aniong male 
homo/bisexuals (4.0%)) ( p  < 0.01). In 10 countries, 
patients infected heterosexually were classified into 
two subgroups: patients living or originating from a 
country where heterosexual transmission is common 
(subgroup 1) and other patients infected heterosexually 
(subgroup 2). The proportion of AIDS cases diagnosed 
with extrapulmonary TB was significantly higher in 
subgroup 1 (16.5%) than in subgroup 2 (4.2%) 
In multivariate analysis, the risk of extrapulmonary 
TB a t  AIDS diagnosis was associated with the country 
of diagnosis (it was 12 times greater in Spain and 15 
times greater in Portugal than in Italy) and with the 
HIV transmission category (three times higher for 
patients infected heterosexually or through intravenous 
drug use than for homo/bisexual males), and it 
decreased with increasing age and was lower in 
females than in males. In the 10 countries where 
heterosexually infected AIDS patients were classified 
into subgroups, the risk of extrapulmonary TB at AIDS 
diagnosis adjusted for country, gender and age was 
niore than seven times greater in subgroup 1 than in 
the male homo/bisexual group (adjusted odds ratio 
[aOR] 7.6; 95% confidence interval [CI] 6.5 to 8.8). 
In subgroup 2, the risk was twice that for male 
homo/bisexuals (aOK 2.0; 95%) CI 1.7 to 2.4). 
( p  < 0.01). 
Pulmonary and extrapulmonary tuberculosis -AIDS cases 
diagnosed in 1994 
The study population (all adult and adolescent AIDS 
cases diagnosed in 1994 in the 11 selected countries) 
included 19,778 cases and accounted for 94.6% of all 
adult/adolescent AIDS cases reported in the WHO 
European Region for this period. Of  these 19,778 
cases, 3805 (19.2%) were diagnosed with TB. Of these 
3805 cases, 1694 (44.5%) were reported with extra- 
pulmonary TB alone, 1868 (49.1%) with pulmonary 
TB alone and 243 (6.4%) with both. As for extra- 
pulmonary TB, the highest proportions of cases with 
TB at  AIDS diagnosis were observed in Spain (42.4%) 
and in Portugal (51.1%). By transniission group, the 
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highest proportions were observed in patients infected 
through intravenous drug use (27.1%) and through 
heterosexual contact (20.3%)). The niriltivariate analysis 
gave results similar to those ohtairied with the 1988- 
1992 data. Chiipared to Italy, the adjusted risks of TB 
were the following (aOK with respective 95% CI): 
Portugal: 13.8 [I 1 . 0  to 17.31; Spain: 8.9 [7.9 to 10.11; 
Greece: 3.8 L2.0 to 7.11; Belgiuin: 3.6 [2.4 to 5.31; 
Aumia: 2.7 [3.6 to 4.51; France: 2.0 111.8 to 2.41; UK: 
1.7 11.3 to 2.11; Deninark: 1.7 [1.0 to 2.91; Gerinany: 
1.6 [1.3 to 2.11; Switzerland: 1.1 [0.7 to 1.71. In the 
nine countries where heterosexually infected cases had 
been classified into subgroups 1 arid 2, the multivariate 
analysis gave similar results to those found with the 
1988-1992 TI3 data. The risk of TB a t  AIDS diagnosis 
was 8.5 times higher in subgroup 1 patients than in 
male hoino/bisexuals, whereas it was only 2.1 times 
higher in subgroup 2 patients. 
The highest incidence rates (per 100,000) of 
AIDS-defining TB were seen in Spain (8.2), Portugal 
(3.4), France (1.1) and Italy (0.7). These four countries 
accounted for 92.3% of all AIDS cases with TB a t  AIDS 
diagnosis, adjusted for reporting ddays, in the 11 
selected countries. The ratio of cases with AIDS- 
defining TB to reported TB cases varied considerably 
across countries, ranging from 0.9% in Germany to 
8% in Spain (6.1% in Portugal, 6.7% in France, 
10.3% in Italy). 
Discussion 
The analysis of the characteristics of patients with TB 
at AIDS diagnosis compared with those ofpatients with 
other AIDS-defining diseases gave consistent results in 
both analyses (extrapulmonary TB between 1988 and 
1992 and all forms of TB in 1994) and showed an 
association between TB and country of diagnosis, 
HIV transmission group, age and gender. It has been 
shown that HIV infection increases both the risk of 
reactivation of latent tuberculous infection and the risk 
ofrapid progression from recent infection to disease [l]. 
In a given country, the incidence of HIV-related TB 
will depend on the prevalence of TB infection, the 
prevalence of HIV infection and the intersection 
between the two populations at risk for each of these 
infections. Although there are few reliable data on the 
prevalence of TB infection in European countries, 
especially in young adults, among whom the risk of 
HIV infection is the highest, the variation in the 
proportion of adult AIDS cases with TB through 
European countries is relatively consistent with the 
differences reported for TB incidence rates. Indeed, the 
proportions of AIDS cases with TB were highest in 
countries where reported TB incidence rates were the 
highest (Portugal, Spain) and lowest in countries with 
the lowest reported TH incidence rates (I)enniark, 
Italy, UK). 
The proportion of cases with TB at  A I I X  diagnosis 
is an indicator of the incidence of T13 in the HIV- 
infected population. However, these TB cases represent 
only part of the total incidence of HIV-associated TB, 
since TI3 cases which occur after AIIIS diagnosis arc 
not reported to the European AIDS surveillance 
system. The proportion of cases with TB at  AIIIS 
diagnosis is therefore a minimum estiindtc of the 
proportion of HIV-infected adults who will develop 
TB. I n  addition, TB cases in HIV-infected childrcri 
were not included in the analysis. 
Comparing the number of AIDS-defining TI3 
cases arid the number of TI3 cases reported to WHO 
[2] gives a niinirnuni estimate of the effect of HIV o n  
TB incidence in each country. This effect varies by 
country. I n  Spain, where both AIDS and TB incidence 
rates are high, the ratio of AIDS-defining T U  cases to 
reported TB cases is 33.8%. In Portugal, where the TI3 
incidence rate is high but the AIDS incidence rate is 
lower than in Spain, the ratio is much lower (6.1%). 
This coinparison should be interpreted with caution 
because TB surveil1,mce varies by country. Uiider- 
reporting of AIDS also occurs, but is probably lower 
than for TE. Since the inclusion of pulmonary TB in 
the AIDS case definition for adults and adolescents, the 
European AIDS surveillance system enables reliable 
data to be collected on part of HIV-associated TI3 (TB 
at AIDS diagnosis). 
By transmission group, the highest risks of 
presenting TB at AIDS diagnosis were found among 
HIV patients infected heterosexually (in particular in 
those originating from or living in an African or 
Caribbean country) and in IDUs. This finding may be 
related to the geographic origin of the patients: the 
prevalence of TB infection is much higher in young 
adults from Africa than is those from Europe [3]. Thus, 
the risk of TB due to reactivation is increased among 
HIV-infected persons of African origin. However, the 
high risk of TB at AIDS diagnosis in HIV patients 
infected through heterosexual contact or intravenous 
drug use could also be due to recent TB infection (or 
reinfection) related to their living conditions. 
In industrialized countries the prevalence of 
tuberculous infection in the general population is 
higher in older subjects [4] who are therefore at greater 
risk of TB by reactivation of latent infection than 
younger subjects. In contrast, among European AIDS 
cases, the risk of presenting TB at AIDS diagnosis is 
higher in young adults than in older subjects, suggesting 
that recent transmission of tuberculous bacilli may play 
a role in the occurrei~ce of TB in young HIV-infected 
subjects. The association between TB and iiiale gender 
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is consistent with a higher TB incidence in males than 
in females in the general population. 
There are two main strategies for preventing TB in 
HIV-infected patients. Isoniazid preventive therapy (for 
6 to 12 months) is effective in preventing TB due 
to reactivation [5], but requires latent tuberculous 
infection in HIV-infected persons to be identified. 
Prompt initiation of therapy in contagious TB patients 
and TB transmission control measures (patient isolation, 
environmental control) in settings where infectious TB 
patients and HIV-infected patients meet (hospitals, 
other settings) would prevent recent infection [6].  
Estimating the relative contribution of both mechan- 
isms (reactivation and recent infection) is essential to 
adapt preventive control measures appropriately. 
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